
- ONCOLOGY Vol 11 No 9
- Volume 11
- Issue 9
The Harry and Elsa Jiler American Cancer Society Clinical Research Professorship
The American Cancer Society announces the establishment of the Harryand Elsa Jiler American Cancer Society Clinical Research Professorship
The American Cancer Society announces the establishment of the Harryand Elsa Jiler American Cancer Society Clinical Research Professorshipand invites interested candidates to submit proposals.
This prestigious grant is intended for an outstanding clinician-scientistin mid-career who has made significant contributions in cancer researchand is considered an exceptional leader in his/her field. Applicants maybe active in any area of clinical or epidemiologic cancer research, includingcancer control, clinical trials directed toward new therapeutic approaches,psychosocial and behavioral, health services, and health policy research.Translational laboratory research that has clinical application is alsoappropriate.
Candidates must be US citizens or permanent residents with at least10 years of experience beyond receipt of the MD or other doctoral degree.Individuals employed by for-profit organizations, federal agencies, oragencies supported entirely by the federal government are not eligible.At the time of the application, the candidate must have a full-time academicor comparable appointment. Generally, candidates must have obtained therank of associate or full professor or the equivalent; however, they mustnot have held the rank of full professor or equivalent for more than 15years.
The Harry and Elsa Jiler American Cancer Society Clinical Research Professorwill be chosen by a peer review process emphasizing past contributionsand future potential, but most importantly, innovation in the field andthe ability to attract young investigators into cancer research. The grantprovides up to $60,000 annually that can be apportioned to salary and/orresearch project support at the discretion of the awardee. The Professorshipwill be awarded for a period of 5 years and may be renewed once, contingentupon continued research productivity and leadership. The Harry and ElsaJiler American Cancer Society Clinical Research Professor will also berequired to be a spokesperson for the American Cancer Society.
The deadline for receipt of applications is October 1, 1997. Applicationsare furnished by the American Cancer Society after discussion with theScientific Program Director (Ralph Vogler, MD; 404-329-7542 or
Articles in this issue
about 28 years ago
UFT: East Meets West in Drug Developmentabout 28 years ago
Rationale for Phase I Study of UFT Plus Leucovorin and Oral JM-216about 28 years ago
Postoperative Adjuvant Chemotherapy for Non-Small-Cell Lung Cancerabout 28 years ago
UFT in Gastric Cancer: Current Status and Future Developmentsabout 28 years ago
Oral UFT and Leucovorin in Patients With Advanced Gastric CarcinomaNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































